cis-11-Eicosenoic acid

We are cis-11-Eicosenoic acid CAS:5561-99-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: cis-11-Eicosenoic acid
Synonyms:11C-EICOSENOIC ACID
EICOSENOIC ACID
11-EICOSENOIC ACID
C20:1 (cis-11)
(Z)-11-Icosenoic acid
 
CAS.NO: 5561-99-9
Molecular Formula: C20H38O2
Molecular Weight: 310.51500
 
Physical and Chemical Properties:
Density: 0.883 g / mL at 25 ° C (lit.)
Boiling point: 426.3ºC at 760 mmHg
Melting point: 23-24 ° C (lit.)
Flash point:> 230 ° F
Refractive index: n20 / D 1.4606 (lit.)
 
Specification:
Appearance:Light yellow paste
Purity:≥98%
 
Packing:25KG/DRUM 
Storage:-20 ° C, sealed, stored in a dry place
Application:Applicationd as a raw material for detergents, cosmetics and advanced lubricants

cis-11-Eicosenoic acid


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.4-Bromo-2-fluorobenzoic acid CAS:112704-79-7 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.4-Dibenzothienylboronic acid CAS:108847-20-7 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
methyl arachidonate View Details
Cytidine 5′-monophosphate disodium salt View Details
2-Butyl-4-chloro-5-formylimidazole View Details
2,5-Dimethoxyphenylboronic acid manufacturer 2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phe nol (2E)-2-butenedioate (1:1) manufacturer Chroman-4-one manufacturer 5-amino-2-methylphenol,sulfuric acid manufacturer 3-Methylbut-2-enoic acid manufacturer